The FDA approved omidubicel on December 8, 2025, the same day parent company Ayrmid announced positive results at the 2025 American Society of Hematology Annual Meeting and Exposition. FDA approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback